CAT and chronic kidney disease: To accomplish this, we utilized AAV9 to express catalase fused to a mitochondrial-targeting sequence driven by the human skeletal actin promoter to limit expression only to myofibers35,50 and this treatment was applied prior to the creation of an iliac AVF in mice with CKD.